Asset Management
Build Your Comparison
Side-by-side financial analysisStock Comparison
BRBI vs PX vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Banks - Diversified
BRBI vs PX vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Asset Management | Asset Management | Banks - Diversified |
| Market Cap | $913M | $909M | $869.15B |
| Revenue (TTM) | $7.41B | $8.99B | $280.33B |
| Net Income (TTM) | $194M | $1.55B | $57.05B |
| Gross Margin | 5.9% | 48.2% | 60.0% |
| Operating Margin | 3.2% | 23.0% | 25.9% |
| Forward P/E | 24.4x | 6.9x | 14.0x |
| Total Debt | $9.93B | $26.99B | $942.38B |
| Cash & Equiv. | $575M | $5.06B | $343.34B |
BRBI vs PX vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 25 | Jun 26 | Return |
|---|---|---|---|
| BRBI BR Partners S.… (BRBI) | 100 | 87.0 | -13.0% |
| P10, Inc. (PX) | 100 | 64.6 | -35.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 183.1 | +83.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRBI vs PX vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRBI is the clearest fit if your priority is quality and efficiency.
- Efficiency ratio 0.0% vs JPM's 0.3% (lower = leaner)
- Efficiency ratio 0.0% vs JPM's 0.3%
PX is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 113.6%, EPS growth 90.3%
- PEG 0.05 vs JPM's 1.07
- 113.6% NII/revenue growth vs JPM's 3.3%
JPM has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.95, yield 1.9%
- 433.9% 10Y total return vs BRBI's 414.7%
- Lower volatility, beta 0.95, current ratio 0.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 113.6% NII/revenue growth vs JPM's 3.3% | |
| Value | Lower P/E (6.9x vs 24.4x) | |
| Quality / Margins | Efficiency ratio 0.0% vs JPM's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.95 vs PX's 1.98 | |
| Dividends | 1.9% yield, 15-year raise streak, vs PX's 1.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +18.8% vs PX's -22.1% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs JPM's 0.3% |
BRBI vs PX vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRBI vs PX vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 37.8x BRBI's $7.4B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to BRBI's 2.6%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $7.4B | $9.0B | $280.3B |
| EBITDAEarnings before interest/tax | — | $3.0B | $81.4B |
| Net IncomeAfter-tax profit | — | $1.6B | $57.0B |
| Free Cash FlowCash after capex | — | $1.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +5.9% | +48.2% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +23.0% | +25.9% |
| Net MarginNet income ÷ Revenue | +2.6% | +17.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | +1.2% | +17.7% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +103.0% | +16.0% |
Valuation Metrics
PX leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, JPM trades at a 67% valuation discount to PX's 47.2x P/E. Adjusting for growth (PEG ratio), PX offers better value at 0.35x vs JPM's 1.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $913M | $909M | $869.1B |
| Enterprise ValueMkt cap + debt − cash | $2.7B | $1.2B | $1.47T |
| Trailing P/EPrice ÷ TTM EPS | 24.43x | 47.19x | 15.52x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 6.92x | 13.97x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.35x | 1.19x |
| EV / EBITDAEnterprise value multiple | 57.04x | 13.56x | 18.03x |
| Price / SalesMarket cap ÷ Revenue | 0.64x | 3.07x | 3.11x |
| Price / BookPrice ÷ Book value/share | 5.88x | 2.35x | 2.40x |
| Price / FCFMarket cap ÷ FCF | 54.18x | 9.41x | 8.62x |
Profitability & Efficiency
PX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BRBI delivers a 23.8% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $15 for PX. PX carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRBI's 12.34x. On the Piotroski fundamental quality scale (0–9), PX scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +23.8% | +15.2% | +15.9% |
| ROA (TTM)Return on assets | +1.5% | +6.9% | +1.3% |
| ROICReturn on invested capital | +2.0% | +19.8% | +4.5% |
| ROCEReturn on capital employed | +2.3% | +24.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 12.34x | 0.68x | 2.60x |
| Net DebtTotal debt minus cash | $9.4B | $21.9B | $599.0B |
| Cash & Equiv.Liquid assets | $575M | $5.1B | $343.3B |
| Total DebtShort + long-term debt | $9.9B | $27.0B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 315.20x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $20,255 today (with dividends reinvested), compared to $6,730 for PX. Over the past 12 months, JPM leads with a +18.8% total return vs PX's -22.1%. The 3-year compound annual growth rate (CAGR) favors JPM at 32.4% vs PX's -11.4% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -15.5% | -22.9% | -3.5% |
| 1-Year ReturnPast 12 months | — | -22.1% | +18.8% |
| 3-Year ReturnCumulative with dividends | — | -30.4% | +131.9% |
| 5-Year ReturnCumulative with dividends | — | -32.7% | +102.6% |
| 10-Year ReturnCumulative with dividends | +41470.8% | -32.7% | +433.9% |
| CAGR (3Y)Annualised 3-year return | — | -11.4% | +32.4% |
Risk & Volatility
JPM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
JPM is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than PX's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 92.2% from its 52-week high vs BRBI's 17.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 1.98x | 0.95x |
| 52-Week HighHighest price in past year | $67.01 | $13.08 | $337.25 |
| 52-Week LowLowest price in past year | $0.00 | $6.97 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +17.3% | +57.7% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 33.6 | 31.9 | 59.6 |
| Avg Volume (50D)Average daily shares traded | 2K | 690K | 7.1M |
Analyst Outlook
JPM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PX as "Buy", JPM as "Buy". Consensus price targets imply 231.1% upside for PX (target: $25) vs 8.9% for JPM (target: $339). For income investors, JPM offers the higher dividend yield at 1.91% vs PX's 1.70%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $25.00 | $338.78 |
| # AnalystsCovering analysts | — | 8 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +1.7% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 4 | 15 |
| Dividend / ShareAnnual DPS | — | $5.95 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.5% | +4.0% |
JPM leads in 4 of 6 categories (Income & Cash Flow, Total Returns). PX leads in 2 (Valuation Metrics, Profitability & Efficiency).
BRBI vs PX vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRBI or PX or JPM a better buy right now?
For growth investors, P10, Inc.
(PX) is the stronger pick with 113. 6% revenue growth year-over-year, versus 3. 3% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate P10, Inc. (PX) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRBI or PX or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 5x versus P10, Inc. at 47. 2x. On forward P/E, P10, Inc. is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: P10, Inc. wins at 0. 05x versus JPMorgan Chase & Co. 's 1. 07x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BRBI or PX or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +102. 6%, compared to -32. 7% for P10, Inc. (PX). Over 10 years, the gap is even starker: BRBI returned +414. 7% versus PX's -32. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRBI or PX or JPM?
By beta (market sensitivity over 5 years), JPMorgan Chase & Co.
(JPM) is the lower-risk stock at 0. 95β versus P10, Inc. 's 1. 98β — meaning PX is approximately 109% more volatile than JPM relative to the S&P 500. On balance sheet safety, P10, Inc. (PX) carries a lower debt/equity ratio of 68% versus 12% for BRBI BR Partners S. A. ADSs — giving it more financial flexibility in a downturn.
05Which is growing faster — BRBI or PX or JPM?
By revenue growth (latest reported year), P10, Inc.
(PX) is pulling ahead at 113. 6% versus 3. 3% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: P10, Inc. grew EPS 90. 3% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRBI or PX or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 2. 6% for BRBI BR Partners S. A. ADSs — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PX leads at 26. 3% versus 3. 2% for BRBI. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRBI or PX or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, P10, Inc. (PX) is the more undervalued stock at a PEG of 0. 05x versus JPMorgan Chase & Co. 's 1. 07x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, P10, Inc. (PX) trades at 6. 9x forward P/E versus 14. 0x for JPMorgan Chase & Co. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PX: 231. 1% to $25. 00.
08Which pays a better dividend — BRBI or PX or JPM?
In this comparison, JPM (1.
9% yield), PX (1. 7% yield) pay a dividend. BRBI does not pay a meaningful dividend and should not be held primarily for income.
09Is BRBI or PX or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 1. 9% yield, +433. 9% 10Y return). P10, Inc. (PX) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +433. 9%, PX: -32. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRBI and PX and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BRBI is a small-cap quality compounder stock; PX is a small-cap high-growth stock; JPM is a large-cap deep-value stock. PX, JPM pay a dividend while BRBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.